glp-1 weight loss before and after How one woman lost 145 pounds — without medication Non-Surgical Medical Weight Loss in

Schwartz B, Gjini P, Gopal DM, Fetterman JL

After decades of research and development, scientists have created next-generation GLP-1 drugs with applications that extend far beyond the treatment of type 2 diabetes

Cardiac Electrophysiology In a randomized, placebo-controlled, active-comparator, crossover study, 30 healthy subjects were administered a single oral dose of empagliflozin 25 mg, empagliflozin 200 mg (8 times the maximum dose), moxifloxacin, and placebo

These high-purity, in vivo-ready reagents are ideal for preclinical research in metabolic, cardiovascular, and neuroprotective investigations

Parkinsons and diabetes